Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated 20 to 30 Years Ago With Engerix-B

NCT02901951 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02901951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02901951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated 20 to 30 Years Ago With Engerix-B
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
October 11, 2016
Completion date
May 1, 2017
Enrollment
106 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccine